Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)

Biological Products, (no Disgnostic Substances)

https://www.recursion.com

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

41S RIO GRANDE STREET
SALT LAKE CITY, UT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/16/2021

Market Cap

1,845,719,700

Shares Outstanding

208,280,000

Weighted SO

215,873,796

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ABSI --.--%

AFMD --.--%

SANA --.--%

RLAY --.--%

IMMX --.--%

CNSP --.--%

HEPA --.--%

FRLN --.--%

AVRO --.--%

Beta

0.8280

Last Div

0.0000

Range

4.97-15.74

Chg

0.0200

Avg Vol

5577540

Mkt Cap

1845719700

Exch

NASDAQ

Country

US

Phone

385 269 0203

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

37.5116

EV Multiple

-4.0495

P/FV

2.7806

Div Yield %

0.0000

P/E

-4.3346

PEG

0.2680

Payout

0.0000

Current Ratio

6.0683

Quick Ratio

6.0683

Cash Ratio

5.5310

DSO

18.7381

DIO

0.0000

Op Cycle

18.7381

DPO

22.1390

CCC

-3.4009

Gross Margin

-0.2605

Op Margin

-8.2425

Pretax Margin

-7.6794

Net Margin

-7.6198

Eff Tax Rate

0.0035

ROA

-0.4832

ROE

-0.7948

ROCE

-0.5880

NI/EBT

0.9922

EBT/EBIT

0.9317

EBIT/Rev

-8.2425

Debt Ratio

0.0511

D/E

0.0678

LT Debt/Cap

0.0377

Total Debt/Cap

0.0635

Int Coverage

-5712.1549

CF/Debt

-8.3638

Equity Multi

1.3275

Rec Turnover

19.4790

Pay Turnover

16.4867

Inv Turnover

0.0000

FA Turnover

0.3148

Asset Turnover

0.0634

OCF/Share

-1.3688

FCF/Share

-1.4269

Cash/Share

1.9659

OCF/Sales

-6.7376

FCF/OCF

1.0425

CF Coverage

-8.3638

ST Coverage

-19.8323

CapEx Coverage

-23.5468

Div&CapEx Cov

-23.5468

P/BV

2.7806

P/B

2.7806

P/S

37.5116

P/E

-4.3346

P/FCF

-5.3407

P/OCF

-4.9021

P/CF

-4.9021

PEG

0.2680

P/S

37.5116

EV Multiple

-4.0495

P/FV

2.7806

DPS

0.0000

Latest Headlines (EST)

The Motley Fool May 27, 00:05 3 Monster Stocks to Hold for the Next 10 Years The Motley Fool May 09, 21:17 Why Recursion Pharmaceuticals Stock Plummeted 24% This Week GlobeNewswire Inc. May 04, 16:45 Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden The Motley Fool Apr 25, 21:10 Why Biohaven Stock Plummeted by More Than 15% Today The Motley Fool Mar 30, 13:30 Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? The Motley Fool Mar 08, 15:02 Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy? The Motley Fool Nov 02, 13:45 Is Recursion Pharmaceuticals a Millionaire-Maker Stock? The Motley Fool Aug 18, 16:34 The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why. Benzinga Jul 02, 02:19 Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor GlobeNewswire Inc. Jun 27, 02:07 Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock The Motley Fool Jan 15, 08:45 3 Biotech Stocks You Can Buy and Hold for the Next Decade The Motley Fool Jan 15, 08:45 3 Biotech Stocks You Can Buy and Hold for the Next Decade The Motley Fool Jan 13, 10:30 Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights The Motley Fool Jan 13, 10:30 Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights The Motley Fool Jan 13, 10:30 Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights The Motley Fool Jan 13, 10:30 Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights The Motley Fool Jan 13, 10:30 Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights The Motley Fool Jan 13, 05:20 Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week MarketWatch Jan 08, 15:11 Nvidia’s stock breaks new ground after healthcare partnerships and ahead of CES MarketWatch Jan 08, 14:48 Nvidia’s stock breaks new ground after healthcare partnerships and ahead of CES

Revenue Product Segmentation